TABLE OF CONTENTS
Volume 27, Issue 9 (21 February 2008)
Review
BCL-2 family regulation by the 20S proteasome inhibitor bortezomib
D A Fennell, A Chacko and L Mutti
Oncogene 27: 1189-1197; advance online publication, September 10, 2007; doi:10.1038/sj.onc.1210744
Original Articles
TAK1 is required for TGF-
1-mediated regulation of matrix metalloproteinase-9 and metastasis
A Safina, M-Q Ren, E Vandette and A V Bakin
Oncogene 27: 1198-1207; advance online publication, September 10, 2007; doi:10.1038/sj.onc.1210768
BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinoma
B C-L Chan, A K-K Ching, K-F To, J C-K Leung, S Chen, Q Li, P B-S Lai, N L-S Tang, P-C Shaw, J Y-H Chan, A E James, K-N Lai, P-L Lim, K K-H Lee and Y-L Chui
Oncogene 27: 1208-1217; advance online publication, August 20, 2007; doi:10.1038/sj.onc.1210733
Sustained TGF exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis
A Gal, T Sjöblom, L Fedorova, S Imreh, H Beug and A Moustakas
Oncogene 27: 1218-1230; advance online publication, August 27, 2007; doi:10.1038/sj.onc.1210741
Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis
D I Lin, M D Lessie, A B Gladden, C H Bassing, K U Wagner and J A Diehl
Oncogene 27: 1231-1242; advance online publication, August 27, 2007; doi:10.1038/sj.onc.1210738
Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast
D Grochova, J Vankova, J Damborsky, B Ravcukova, J Smarda, B Vojtesek and J Smardova
Oncogene 27: 1243-1252; advance online publication, September 3, 2007; doi:10.1038/sj.onc.1210748
Human and mouse cyclin D2 splice variants: transforming activity and subcellular localization
C Denicourt, P Legault, F-A C McNabb and E Rassart
Oncogene 27: 1253-1262; advance online publication, September 17, 2007; doi:10.1038/sj.onc.1210750
The histone deacetylase inhibitor trichostatin A induces GADD45
expression via Oct and NF-Y binding sites
M R Campanero, A Herrero and V Calvo
Oncogene 27: 1263-1272; advance online publication, August 27, 2007; doi:10.1038/sj.onc.1210735
Protein kinase C
-CARMA3 signaling axis links Ras to NF-
B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells
C Mahanivong, H M Chen, S W Yee, Z K Pan, Z Dong and S Huang
Oncogene 27: 1273-1280; advance online publication, August 27, 2007; doi:10.1038/sj.onc.1210746
The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies
D Gast, S Riedle, Y Issa, M Pfeifer, P Beckhove, M P Sanderson, M Arlt, G Moldenhauer, M Fogel, A Krüger and P Altevogt
Oncogene 27: 1281-1289; advance online publication, October 22, 2007; doi:10.1038/sj.onc.1210747
Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma
M R Akbari, R Malekzadeh, D Nasrollahzadeh, D Amanian, F Islami, S Li, I Zandvakili, R Shakeri, M Sotoudeh, K Aghcheli, R Salahi, A Pourshams, S Semnani, P Boffetta, S M Dawsey, P Ghadirian and S A Narod
Oncogene 27: 1290-1296; advance online publication, August 27, 2007; doi:10.1038/sj.onc.1210739
G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1
J A Lee, J E Park, D H Lee, S G Park, P K Myung, B C Park and S Cho
Oncogene 27: 1297-1305; advance online publication, August 20, 2007; doi:10.1038/sj.onc.1210740
Short Communications
P-TEFb inhibitors interfere with activation of p53 by DNA-damaging agents
S K Radhakrishnan, U G Bhat, M Halasi and A L Gartel
Oncogene 27: 1306-1309; advance online publication, September 3, 2007; doi:10.1038/sj.onc.1210737
Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1
levels in gliomas
O-H Lee, J Xu, J Fueyo, M M Alonso, D Liu, V Martin, H Jiang, Y Piao, T J Liu and C Gomez-Manzano
Oncogene 27: 1310-1314; advance online publication, August 20, 2007; doi:10.1038/sj.onc.1210731
Cellular functions of 14-3-3
in apoptosis and cell adhesion emphasize its oncogenic character
M Niemantsverdriet, K Wagner, M Visser and C Backendorf
Oncogene 27: 1315-1319; advance online publication, August 20, 2007; doi:10.1038/sj.onc.1210742
Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells
M Sauermann, Ö Sahin, H Sültmann, F Hahne, S Blaszkiewicz, M Majety, K Zatloukal, L Füzesi, A Poustka, S Wiemann and D Arlt
Oncogene 27: 1320-1326; advance online publication, August 27, 2007; doi:10.1038/sj.onc.1210743
An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II
V H Cowling and M D Cole
Oncogene 27: 1327-1332; advance online publication, August 20, 2007; doi:10.1038/sj.onc.1210734
Oncogenomics
The ternary complex factor Net/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1
C Gross, H Dubois-Pot and B Wasylyk
Oncogene 27: 1333-1341; advance online publication, August 20, 2007; doi:10.1038/sj.onc.1210736
Corrigenda
Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis FREE
Z Wang, Y P Rong, M H Malone, M C Davis, F Zhong and C W Distelhorst
Oncogene 27: 1342; doi:10.1038/sj.onc.1211001
The effect of Hus1 on ionizing radiation sensitivity is associated with homologous recombination repair but is independent of nonhomologous end-joining FREE
X Wang, B Hu, R S Weiss and Y Wang
Oncogene 27: 1343; doi:10.1038/onc.2008.1
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity FREE
J Sun, M A Blaskovich, R Jove, S K Livingston, D Coppola and S M Sebti
Oncogene 27: 1344; doi:10.1038/sj.onc.1211028
